Skip to main
WALD

WALD Stock Forecast & Price Target

WALD Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Waldencast is a company with strong potential for growth, with their Obagi skincare segment showing impressive growth in both their DTC channel and international market. However, their Milk Makeup segment has faced challenges, particularly in the international market, which may need to be addressed for overall growth. The ongoing SEC investigation and potential dilution from future securities offerings may also have an effect on the company's growth potential. Additionally, the reliance on one main distributor in the U.S. and potential supply chain pressures could also impact the business. Overall, while the company's brands have room for growth, investors should be aware of potential risks and uncertainties in the future.

Bears say

Waldencast is experiencing declining sales and profitability, with a lack of guidance for future years due to the ongoing strategic review and potential divestment of assets. Their main revenue driver, the Obagi Medical segment, may face headwinds from currency fluctuations and other industry-specific risks. The company's high level of debt and uncertainty around their future direction make it a risky investment.

WALD has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Waldencast Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Waldencast Acquisition Corp (WALD) Forecast

Analysts have given WALD a Buy based on their latest research and market trends.

According to 3 analysts, WALD has a Buy consensus rating as of Jun 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Waldencast Acquisition Corp (WALD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.